<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:fil="http://Tpia/20260331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tpia-20260331.xsd" xlink:type="simple"/>
    <context id="Y26Q1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="E26Q1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="I260608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
        </entity>
        <period>
            <instant>2026-06-08</instant>
        </period>
    </context>
    <context id="E25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="E26Q1_StClStock-SeriesBPrefStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E25_StClStock-SeriesBPrefStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="E26Q1_StClStock-SeriesAPrefStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E25_StClStock-SeriesAPrefStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="Y25Q1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="Y26Q1_StClStock-SeriesBPrefStock_StEqComps-PrefStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="Y26Q1_StClStock-SeriesAPrefStock_StEqComps-PrefStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="Y26Q1_StEqComps-CommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="Y26Q1_StEqComps-AddPaidInCap">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="Y26Q1_StEqComps-RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="E25_StClStock-SeriesBPrefStock_StEqComps-PrefStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="E25_StClStock-SeriesAPrefStock_StEqComps-PrefStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="E25_StEqComps-CommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="E25_StEqComps-AddPaidInCap">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="E25_StEqComps-RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="E26Q1_StClStock-SeriesBPrefStock_StEqComps-PrefStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E26Q1_StClStock-SeriesAPrefStock_StEqComps-PrefStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E26Q1_StEqComps-CommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E26Q1_StEqComps-AddPaidInCap">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E26Q1_StEqComps-RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="E24_StClStock-SeriesBPrefStock_StEqComps-PrefStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="E24_StClStock-SeriesAPrefStock_StEqComps-PrefStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="E24_StEqComps-CommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="E24_StEqComps-AddPaidInCap">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="E24_StEqComps-RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="Y25Q1_StClStock-SeriesBPrefStock_StEqComps-PrefStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="Y25Q1_StClStock-SeriesAPrefStock_StEqComps-PrefStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="Y25Q1_StEqComps-CommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="Y25Q1_StEqComps-AddPaidInCap">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="Y25Q1_StEqComps-RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="E25Q1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="E25Q1_StClStock-SeriesBPrefStock_StEqComps-PrefStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="E25Q1_StClStock-SeriesAPrefStock_StEqComps-PrefStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="E25Q1_StEqComps-CommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="E25Q1_StEqComps-AddPaidInCap">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="E25Q1_StEqComps-RetainedEarnings">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="E26Q1_PpeByType-Equipment">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E26Q1_FiniteLivedIntangibleAssetsByMajorClass-IntellectualProp">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="Y26Q1_DebtInstr-ConvertibleDebt1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fil:ConvertibleDebt1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="Y25Q1_DebtInstr-ConvertibleDebt1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fil:ConvertibleDebt1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="Y26Q1_DebtInstr-Warrants">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fil:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="Y25Q1_DebtInstr-Warrants">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fil:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="E25_FiniteLivedIntangibleAssetsByMajorClass-IntellectualProp">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="Y26Q1_RelPtyTrnsByRelPty-MajorShareholder">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MajorShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="Y25Q1_RelPtyTrnsByRelPty-MajorShareholder">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MajorShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="E26Q1_RelPtyTrnsByRelPty-MajorShareholder">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MajorShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="Y26Q1_RelPtyTrnsByRelPty-Ceo">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:CeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="Y25Q1_RelPtyTrnsByRelPty-Ceo">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:CeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="E26Q1_RelPtyTrnsByRelPty-BoardCompensation">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:BoardCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E25_RelPtyTrnsByRelPty-BoardCompensation">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:BoardCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="Y26Q1_ShortTermDebtType-LenderA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="D250422_ShortTermDebtType-LenderGFormerlyLenderA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderGFormerlyLenderAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="Y26Q1_ShortTermDebtType-LenderGFormerlyLenderA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderGFormerlyLenderAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="Y26Q1_ShortTermDebtType-LenderB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="Y26Q1_ShortTermDebtType-LenderC">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="Y26Q1_ShortTermDebtType-LenderE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="Y26Q1_ShortTermDebtType-LenderF">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="Y26Q1_ShortTermDebtType-LenderG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="Y26Q1_ShortTermDebtType-LenderH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="Y26Q1_ShortTermDebtType-LenderI">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="E26Q1_ShortTermDebtType-LenderGFormerlyLenderA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderGFormerlyLenderAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E25_ShortTermDebtType-LenderGFormerlyLenderA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderGFormerlyLenderAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="E26Q1_ShortTermDebtType-LenderB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E25_ShortTermDebtType-LenderB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="Y26Q1_ShortTermDebtType-LenderD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="E26Q1_ShortTermDebtType-LenderD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E25_ShortTermDebtType-LenderD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="E26Q1_ShortTermDebtType-LenderE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E25_ShortTermDebtType-LenderE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="E26Q1_ShortTermDebtType-LenderF">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E25_ShortTermDebtType-LenderF">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="E26Q1_ShortTermDebtType-LenderG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E25_ShortTermDebtType-LenderG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="E26Q1_ShortTermDebtType-LenderH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E25_ShortTermDebtType-LenderH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="E26Q1_ShortTermDebtType-LenderI">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="E25_ShortTermDebtType-LenderI">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fil:LenderIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="I240623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
        </entity>
        <period>
            <instant>2024-06-23</instant>
        </period>
    </context>
    <context id="I240624">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
        </entity>
        <period>
            <instant>2024-06-24</instant>
        </period>
    </context>
    <context id="Y25Q1_StockIssuance-StockIssuance8_StEqComps-CommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fil:StockIssuanceAxis">fil:StockIssuance8Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="Y25Q1_StockIssuance-StockIssuance8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fil:StockIssuanceAxis">fil:StockIssuance8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="Y25_StEqComps-CommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="Y25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="Y25Q1_PlanName-MayConsultingAgreement">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fil:MayConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="Y24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001763329</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="UsdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="Y26Q1" id="fact1">0001763329</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="Y26Q1" id="fact2">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityRegistrantName contextRef="Y26Q1" id="fact3">AIBOTICS, INC.</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="Y26Q1" id="fact4">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="Y26Q1" id="fact5">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="Y26Q1" id="fact6">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentType contextRef="Y26Q1" id="ixv-6232">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="Y26Q1" id="ixv-6233">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="Y26Q1" id="ixv-6234">2026-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="Y26Q1" id="ixv-6235">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="Y26Q1" id="ixv-6236">000-56022</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode contextRef="Y26Q1" id="ixv-6237">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="Y26Q1" id="ixv-6238">87-0645794</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="Y26Q1" id="ixv-6239">100 SE 2nd Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="Y26Q1" id="ixv-6240">Suite 2000</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="Y26Q1" id="ixv-6241">Miami</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="Y26Q1" id="ixv-6242">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="Y26Q1" id="ixv-6243">33131</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="Y26Q1" id="ixv-6244">954</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="Y26Q1" id="ixv-6245">233-3511</dei:LocalPhoneNumber>
    <dei:EntityCurrentReportingStatus contextRef="Y26Q1" id="ixv-6246">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="Y26Q1" id="ixv-6247">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="Y26Q1" id="ixv-6248">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="Y26Q1" id="ixv-6249">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="Y26Q1" id="ixv-6250">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="Y26Q1" id="ixv-6251">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="I260608"
      decimals="INF"
      id="ixv-6252"
      unitRef="Shares">681985644</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Cash
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6253"
      unitRef="USD">288858</us-gaap:Cash>
    <us-gaap:Cash contextRef="E25" decimals="INF" id="ixv-6254" unitRef="USD">255940</us-gaap:Cash>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6255"
      unitRef="USD">1667</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="E25" decimals="INF" id="ixv-6256" unitRef="USD">14167</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:InventoryNet
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6257"
      unitRef="USD">40525</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="E25" decimals="128" id="ixv-6258" unitRef="USD">0</us-gaap:InventoryNet>
    <us-gaap:AssetsCurrent
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6259"
      unitRef="USD">331050</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="E25" decimals="INF" id="ixv-6260" unitRef="USD">270107</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="E26Q1"
      decimals="128"
      id="ixv-6261"
      unitRef="USD">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="E25" decimals="128" id="ixv-6262" unitRef="USD">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6263"
      unitRef="USD">440183</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="E25" decimals="INF" id="ixv-6264" unitRef="USD">604566</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:Assets
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6265"
      unitRef="USD">771233</us-gaap:Assets>
    <us-gaap:Assets contextRef="E25" decimals="INF" id="ixv-6266" unitRef="USD">874673</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6267"
      unitRef="USD">570435</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="E25" decimals="INF" id="ixv-6268" unitRef="USD">532302</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6269"
      unitRef="USD">879000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="E25" decimals="INF" id="ixv-6270" unitRef="USD">807000</us-gaap:AccruedLiabilitiesCurrent>
    <fil:AccruedExpensesRelatedParty
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6271"
      unitRef="USD">248281</fil:AccruedExpensesRelatedParty>
    <fil:AccruedExpensesRelatedParty contextRef="E25" decimals="INF" id="ixv-6272" unitRef="USD">216734</fil:AccruedExpensesRelatedParty>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6273"
      unitRef="USD">1193018</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="E25" decimals="INF" id="ixv-6274" unitRef="USD">1118269</us-gaap:ConvertibleNotesPayableCurrent>
    <fil:DueToRelatedParties
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6275"
      unitRef="USD">165000</fil:DueToRelatedParties>
    <fil:DueToRelatedParties contextRef="E25" decimals="INF" id="ixv-6276" unitRef="USD">165000</fil:DueToRelatedParties>
    <fil:ShareholderLoan
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6277"
      unitRef="USD">1995600</fil:ShareholderLoan>
    <fil:ShareholderLoan contextRef="E25" decimals="INF" id="ixv-6278" unitRef="USD">1995600</fil:ShareholderLoan>
    <us-gaap:Liabilities
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6279"
      unitRef="USD">5051334</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="E25" decimals="INF" id="ixv-6280" unitRef="USD">4834905</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="E25_StClStock-SeriesBPrefStock"
      decimals="INF"
      id="ixv-6281"
      unitRef="UsdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="E26Q1_StClStock-SeriesBPrefStock"
      decimals="INF"
      id="ixv-6282"
      unitRef="UsdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="E25_StClStock-SeriesBPrefStock"
      decimals="INF"
      id="ixv-6283"
      unitRef="Shares">1500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="E26Q1_StClStock-SeriesBPrefStock"
      decimals="INF"
      id="ixv-6284"
      unitRef="Shares">1500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="E25_StClStock-SeriesBPrefStock"
      decimals="INF"
      id="ixv-6285"
      unitRef="Shares">200000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="E25_StClStock-SeriesBPrefStock"
      decimals="INF"
      id="ixv-6286"
      unitRef="Shares">200000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="E26Q1_StClStock-SeriesBPrefStock"
      decimals="INF"
      id="ixv-6287"
      unitRef="Shares">200000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="E26Q1_StClStock-SeriesBPrefStock"
      decimals="INF"
      id="ixv-6288"
      unitRef="Shares">200000</us-gaap:PreferredStockSharesOutstanding>
    <fil:PreferredLiquidation
      contextRef="E26Q1_StClStock-SeriesBPrefStock"
      decimals="INF"
      id="ixv-6289"
      unitRef="USD">0</fil:PreferredLiquidation>
    <fil:PreferredLiquidation
      contextRef="E25_StClStock-SeriesBPrefStock"
      decimals="INF"
      id="ixv-6290"
      unitRef="USD">0</fil:PreferredLiquidation>
    <us-gaap:PreferredStockValue
      contextRef="E26Q1_StClStock-SeriesBPrefStock"
      decimals="INF"
      id="ixv-6291"
      unitRef="USD">200</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="E25_StClStock-SeriesBPrefStock"
      decimals="INF"
      id="ixv-6292"
      unitRef="USD">200</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="E25_StClStock-SeriesAPrefStock"
      decimals="INF"
      id="ixv-6293"
      unitRef="UsdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="E26Q1_StClStock-SeriesAPrefStock"
      decimals="INF"
      id="ixv-6294"
      unitRef="UsdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="E26Q1_StClStock-SeriesAPrefStock"
      decimals="INF"
      id="ixv-6295"
      unitRef="Shares">0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="E25_StClStock-SeriesAPrefStock"
      decimals="INF"
      id="ixv-6296"
      unitRef="Shares">0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockValue
      contextRef="E26Q1_StClStock-SeriesAPrefStock"
      decimals="128"
      id="ixv-6297"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="E25_StClStock-SeriesAPrefStock"
      decimals="128"
      id="ixv-6298"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="E25"
      decimals="INF"
      id="ixv-6299"
      unitRef="UsdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6300"
      unitRef="UsdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6301"
      unitRef="Shares">7500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="E25"
      decimals="INF"
      id="ixv-6302"
      unitRef="Shares">7500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6303"
      unitRef="Shares">539367487</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6304"
      unitRef="Shares">539367487</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="E25"
      decimals="INF"
      id="ixv-6305"
      unitRef="Shares">486895359</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="E25"
      decimals="INF"
      id="ixv-6306"
      unitRef="Shares">486895359</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6307"
      unitRef="USD">539367</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="E25" decimals="INF" id="ixv-6308" unitRef="USD">486895</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6309"
      unitRef="USD">8623444</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="E25" decimals="INF" id="ixv-6310" unitRef="USD">8577680</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6311"
      unitRef="USD">-13443112</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="E25" decimals="INF" id="ixv-6312" unitRef="USD">-13025007</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6313"
      unitRef="USD">-4280101</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="E25" decimals="INF" id="ixv-6314" unitRef="USD">-3960232</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6315"
      unitRef="USD">771233</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="E25" decimals="INF" id="ixv-6316" unitRef="USD">874673</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="Y26Q1"
      decimals="128"
      id="ixv-6317"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6318"
      unitRef="USD">2183</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="Y26Q1"
      decimals="128"
      id="ixv-6319"
      unitRef="USD">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6320"
      unitRef="USD">2183</us-gaap:GrossProfit>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6321"
      unitRef="USD">359463</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6322"
      unitRef="USD">531647</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6323"
      unitRef="USD">359463</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6324"
      unitRef="USD">531647</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6325"
      unitRef="USD">-359463</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6326"
      unitRef="USD">-529464</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6327"
      unitRef="USD">58642</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6328"
      unitRef="USD">61933</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6329"
      unitRef="USD">-58642</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6330"
      unitRef="USD">-61933</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6331"
      unitRef="USD">-418105</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6332"
      unitRef="USD">-591397</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Y26Q1"
      decimals="128"
      id="ixv-6333"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Y25Q1"
      decimals="128"
      id="ixv-6334"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6335"
      unitRef="USD">-418105</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6336"
      unitRef="USD">-591397</us-gaap:NetIncomeLoss>
    <fil:NetLossPerShareBasicAndDiluted
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6337"
      unitRef="UsdPerShare">-0</fil:NetLossPerShareBasicAndDiluted>
    <fil:NetLossPerShareBasicAndDiluted
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6338"
      unitRef="UsdPerShare">-0.01</fil:NetLossPerShareBasicAndDiluted>
    <fil:AverageNumberOfCommonShareOutstandingBasicAndDiluted
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6339"
      unitRef="Shares">521034848</fil:AverageNumberOfCommonShareOutstandingBasicAndDiluted>
    <fil:AverageNumberOfCommonShareOutstandingBasicAndDiluted
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6340"
      unitRef="Shares">44256753</fil:AverageNumberOfCommonShareOutstandingBasicAndDiluted>
    <us-gaap:SharesOutstanding
      contextRef="E25_StClStock-SeriesBPrefStock_StEqComps-PrefStock"
      decimals="INF"
      id="ixv-6341"
      unitRef="Shares">200000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="E25_StClStock-SeriesBPrefStock_StEqComps-PrefStock"
      decimals="INF"
      id="ixv-6342"
      unitRef="USD">200</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="E25_StClStock-SeriesAPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6343"
      unitRef="Shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="E25_StClStock-SeriesAPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6344"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="E25_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6345"
      unitRef="Shares">486895359</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="E25_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6346"
      unitRef="USD">486895</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="E25_StEqComps-AddPaidInCap"
      decimals="INF"
      id="ixv-6347"
      unitRef="USD">8577680</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="E25_StEqComps-RetainedEarnings"
      decimals="INF"
      id="ixv-6348"
      unitRef="USD">-13025007</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="E25" decimals="INF" id="ixv-6349" unitRef="USD">-3960232</us-gaap:StockholdersEquity>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y26Q1_StClStock-SeriesBPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6350"
      unitRef="USD">0</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y26Q1_StClStock-SeriesBPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6351"
      unitRef="USD">0</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y26Q1_StClStock-SeriesAPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6352"
      unitRef="USD">0</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y26Q1_StClStock-SeriesAPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6353"
      unitRef="USD">0</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpensesShare
      contextRef="Y26Q1_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6354"
      unitRef="Shares">26900000</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpensesShare>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y26Q1_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6355"
      unitRef="USD">26900</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y26Q1_StEqComps-AddPaidInCap"
      decimals="INF"
      id="ixv-6356"
      unitRef="USD">-5380</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y26Q1_StEqComps-RetainedEarnings"
      decimals="128"
      id="ixv-6357"
      unitRef="USD">0</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6358"
      unitRef="USD">21520</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:SharesIssuedForCashSettlementOfAccountsPayableAndAccruedExpensesAndThirdPartyCostsShares
      contextRef="Y26Q1_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6359"
      unitRef="Shares">25572128</fil:SharesIssuedForCashSettlementOfAccountsPayableAndAccruedExpensesAndThirdPartyCostsShares>
    <fil:SharesIssuedForCashSettlementOfAccountsPayableAndAccruedExpensesAndThirdPartyCosts
      contextRef="Y26Q1_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6360"
      unitRef="USD">25572</fil:SharesIssuedForCashSettlementOfAccountsPayableAndAccruedExpensesAndThirdPartyCosts>
    <fil:SharesIssuedForCashSettlementOfAccountsPayableAndAccruedExpensesAndThirdPartyCosts
      contextRef="Y26Q1_StEqComps-AddPaidInCap"
      decimals="INF"
      id="ixv-6361"
      unitRef="USD">51144</fil:SharesIssuedForCashSettlementOfAccountsPayableAndAccruedExpensesAndThirdPartyCosts>
    <fil:SharesIssuedForCashSettlementOfAccountsPayableAndAccruedExpensesAndThirdPartyCosts
      contextRef="Y26Q1_StEqComps-RetainedEarnings"
      decimals="128"
      id="ixv-6362"
      unitRef="USD">0</fil:SharesIssuedForCashSettlementOfAccountsPayableAndAccruedExpensesAndThirdPartyCosts>
    <fil:SharesIssuedForCashSettlementOfAccountsPayableAndAccruedExpensesAndThirdPartyCosts
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6363"
      unitRef="USD">76716</fil:SharesIssuedForCashSettlementOfAccountsPayableAndAccruedExpensesAndThirdPartyCosts>
    <us-gaap:NetIncomeLoss
      contextRef="Y26Q1_StClStock-SeriesBPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6364"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Y26Q1_StClStock-SeriesBPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6365"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Y26Q1_StClStock-SeriesAPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6366"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Y26Q1_StClStock-SeriesAPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6367"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Y26Q1_StEqComps-RetainedEarnings"
      decimals="INF"
      id="ixv-6368"
      unitRef="USD">-418105</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6369"
      unitRef="USD">-418105</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="E26Q1_StClStock-SeriesBPrefStock_StEqComps-PrefStock"
      decimals="INF"
      id="ixv-6370"
      unitRef="Shares">200000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="E26Q1_StClStock-SeriesBPrefStock_StEqComps-PrefStock"
      decimals="INF"
      id="ixv-6371"
      unitRef="USD">200</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="E26Q1_StClStock-SeriesAPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6372"
      unitRef="Shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="E26Q1_StClStock-SeriesAPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6373"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="E26Q1_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6374"
      unitRef="Shares">539367487</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="E26Q1_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6375"
      unitRef="USD">539367</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="E26Q1_StEqComps-AddPaidInCap"
      decimals="INF"
      id="ixv-6376"
      unitRef="USD">8623444</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="E26Q1_StEqComps-RetainedEarnings"
      decimals="INF"
      id="ixv-6377"
      unitRef="USD">-13443112</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6378"
      unitRef="USD">-4280101</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="E24_StClStock-SeriesBPrefStock_StEqComps-PrefStock"
      decimals="INF"
      id="ixv-6379"
      unitRef="Shares">200000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="E24_StClStock-SeriesBPrefStock_StEqComps-PrefStock"
      decimals="INF"
      id="ixv-6380"
      unitRef="USD">200</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="E24_StClStock-SeriesAPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6381"
      unitRef="Shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="E24_StClStock-SeriesAPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6382"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="E24_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6383"
      unitRef="Shares">39990903</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="E24_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6384"
      unitRef="USD">39991</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="E24_StEqComps-AddPaidInCap"
      decimals="INF"
      id="ixv-6385"
      unitRef="USD">7374297</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="E24_StEqComps-RetainedEarnings"
      decimals="INF"
      id="ixv-6386"
      unitRef="USD">-10809256</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="E24" decimals="INF" id="ixv-6387" unitRef="USD">-3394768</us-gaap:StockholdersEquity>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y25Q1_StClStock-SeriesBPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6388"
      unitRef="USD">0</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y25Q1_StClStock-SeriesBPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6389"
      unitRef="USD">0</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y25Q1_StClStock-SeriesAPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6390"
      unitRef="USD">0</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y25Q1_StClStock-SeriesAPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6391"
      unitRef="USD">0</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpensesShare
      contextRef="Y25Q1_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6392"
      unitRef="Shares">5253234</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpensesShare>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y25Q1_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6393"
      unitRef="USD">5253</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y25Q1_StEqComps-AddPaidInCap"
      decimals="INF"
      id="ixv-6394"
      unitRef="USD">143941</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y25Q1_StEqComps-RetainedEarnings"
      decimals="128"
      id="ixv-6395"
      unitRef="USD">0</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6396"
      unitRef="USD">149194</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <us-gaap:NetIncomeLoss
      contextRef="Y25Q1_StClStock-SeriesBPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6397"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Y25Q1_StClStock-SeriesBPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6398"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Y25Q1_StClStock-SeriesAPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6399"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Y25Q1_StClStock-SeriesAPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6400"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Y25Q1_StEqComps-CommonStock"
      decimals="128"
      id="ixv-6401"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Y25Q1_StEqComps-CommonStock"
      decimals="128"
      id="ixv-6402"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Y25Q1_StEqComps-AddPaidInCap"
      decimals="128"
      id="ixv-6403"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Y25Q1_StEqComps-RetainedEarnings"
      decimals="INF"
      id="ixv-6404"
      unitRef="USD">-591397</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6405"
      unitRef="USD">-591397</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="E25Q1_StClStock-SeriesBPrefStock_StEqComps-PrefStock"
      decimals="INF"
      id="ixv-6406"
      unitRef="Shares">200000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="E25Q1_StClStock-SeriesBPrefStock_StEqComps-PrefStock"
      decimals="INF"
      id="ixv-6407"
      unitRef="USD">200</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="E25Q1_StClStock-SeriesAPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6408"
      unitRef="Shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="E25Q1_StClStock-SeriesAPrefStock_StEqComps-PrefStock"
      decimals="128"
      id="ixv-6409"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="E25Q1_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6410"
      unitRef="Shares">45244137</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="E25Q1_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6411"
      unitRef="USD">45244</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="E25Q1_StEqComps-AddPaidInCap"
      decimals="INF"
      id="ixv-6412"
      unitRef="USD">7518238</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="E25Q1_StEqComps-RetainedEarnings"
      decimals="INF"
      id="ixv-6413"
      unitRef="USD">-11400653</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="E25Q1"
      decimals="INF"
      id="ixv-6414"
      unitRef="USD">-3836971</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6415"
      unitRef="USD">-418105</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6416"
      unitRef="USD">-591397</us-gaap:NetIncomeLoss>
    <us-gaap:AdjustmentForAmortization
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6417"
      unitRef="USD">169956</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6418"
      unitRef="USD">164234</us-gaap:AdjustmentForAmortization>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6419"
      unitRef="USD">-12500</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="Y25Q1"
      decimals="128"
      id="ixv-6420"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6421"
      unitRef="USD">40525</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="Y25Q1"
      decimals="128"
      id="ixv-6422"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6423"
      unitRef="USD">136369</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6424"
      unitRef="USD">308870</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6425"
      unitRef="USD">-31547</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6426"
      unitRef="USD">-17933</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <fil:IncreaseDecreaseInAccruedExpensesRelatedParty
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6427"
      unitRef="USD">72000</fil:IncreaseDecreaseInAccruedExpensesRelatedParty>
    <fil:IncreaseDecreaseInAccruedExpensesRelatedParty
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6428"
      unitRef="USD">72000</fil:IncreaseDecreaseInAccruedExpensesRelatedParty>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6429"
      unitRef="USD">-36258</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6430"
      unitRef="USD">-28360</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Y26Q1"
      decimals="128"
      id="ixv-6431"
      unitRef="USD">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Y25Q1"
      decimals="128"
      id="ixv-6432"
      unitRef="USD">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6433"
      unitRef="USD">98000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="Y25Q1"
      decimals="128"
      id="ixv-6434"
      unitRef="USD">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6435"
      unitRef="USD">28824</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="Y25Q1"
      decimals="128"
      id="ixv-6436"
      unitRef="USD">0</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6437"
      unitRef="USD">69176</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Y25Q1"
      decimals="128"
      id="ixv-6438"
      unitRef="USD">0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6439"
      unitRef="USD">32918</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6440"
      unitRef="USD">-28360</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="E25" decimals="INF" id="ixv-6441" unitRef="USD">255940</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="E24" decimals="INF" id="ixv-6442" unitRef="USD">185097</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6443"
      unitRef="USD">288858</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="E25Q1"
      decimals="INF"
      id="ixv-6444"
      unitRef="USD">156737</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="Y26Q1"
      decimals="128"
      id="ixv-6445"
      unitRef="USD">0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="Y25Q1"
      decimals="128"
      id="ixv-6446"
      unitRef="USD">0</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="Y26Q1"
      decimals="128"
      id="ixv-6447"
      unitRef="USD">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="Y25Q1"
      decimals="128"
      id="ixv-6448"
      unitRef="USD">0</us-gaap:IncomeTaxesPaidNet>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6449"
      unitRef="USD">21520</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6450"
      unitRef="USD">149194</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedForCashAndSettlementOfAccruedInterestNetOfIssuanceCosts
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6451"
      unitRef="USD">76716</fil:CommonStockIssuedForCashAndSettlementOfAccruedInterestNetOfIssuanceCosts>
    <fil:CommonStockIssuedForCashAndSettlementOfAccruedInterestNetOfIssuanceCosts
      contextRef="Y25Q1"
      decimals="128"
      id="ixv-6452"
      unitRef="USD">0</fil:CommonStockIssuedForCashAndSettlementOfAccruedInterestNetOfIssuanceCosts>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="Y26Q1" id="ixv-3433">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;NOTE 1 &#x2013;&#160;ORGANIZATION AND DESCRIPTION OF BUSINESS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Organization and Business Activity&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The Company was incorporated in Nevada on January 21, 2000, under the name RM Investors, Inc. In December 2020, we entered into definitive agreements with Ehave, Inc., an Ontario corporation (&#x201c;Ehave&#x201d;), AIBiotics Therapies Inc., a Florida corporation and wholly owned subsidiary of Ehave (&#x201c;MYC&#x201d;), and the former and current directors of 20/20 Global that provide for: (i) 20/20 Global&#x2019;s purchase for $350,000 in cash of all of the outstanding stock of MYC from Ehave under a Stock Purchase Agreement, resulting in MYC becoming a wholly owned subsidiary of 20/20 Global; and (ii)&#160;the change of control of 20/20 Global&#x2019;s board of directors and management under a Change of Control and Funding Agreement. In a related transaction, Ehave agreed to purchase 9,793,754 shares of 20/20 Global common stock, which constitute approximately 75.77% of the then-issued and outstanding shares of 20/20 Global&#x2019;s common stock, for $350,000 in cash through a Stock Purchase Agreement (&#x201c;MYC SPA&#x201d;) with 20/20 Global stockholders Mark D. Williams, Colin Gibson, and The Robert and Joanna Williams Trust. As of March 31, 2026 Ehave&#x2019;s ownership has since been diluted to 21.4%.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;On January 19, 2021, the above transaction closed. Because the former shareholder of AIBiotics Therapies, Inc. acquired 75.77% of the Company&#x2019;s then-outstanding stock and there was a change in control of the board of directors, the transaction was accounted for as a reverse merger in which AIBiotics Therapies, Inc. was deemed to be the accounting acquirer and the Company the legal acquirer. Subsequent to the transaction, the Company changed its name from 20/20 Global, Inc. to AIBiotics Therapies, Inc.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;As a result of the transaction, the historical consolidated financial statements of the Company for periods prior to the date of the transaction are those of AIBiotics Therapies, Inc., as the accounting acquirer, and all references to the consolidated financial statements of the Company apply to the historical financial statements of AIBiotics Therapies, Inc. prior to the transaction and the consolidated financial statements of the Company subsequent to the transaction.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;On November 17, 2024, the Company created a new Florida-based subsidiary, NPD Genius, LLC (&#x201c;NPD&#x201d;). &#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;On February 3, 2025, Mycotopia Therapies, Inc. amended its articles of incorporation to change its name to Aibotics Inc., (the &#x201c;Name Change&#x201d;).&lt;/span&gt;&lt;/p&gt;
</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="Y26Q1" id="ixv-3462">&lt;p style="font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:18pt;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;NOTE 2 - GOING&#160;CONCERN&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. To date, the Company has generated minimal revenues, experienced negative operating cash flows and has incurred operating losses since inception. Management expects the Company to continue to fund its operations primarily through the issuance of debt or equity.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;For the three months ended March 31, 2026, the Company incurred a net loss of $418,105, had negative cash flows from operations of $36,258 and may incur additional future losses. At March 31, 2026, the Company had total current assets of $331,050 and total current liabilities of $5,051,334 resulting in a working capital deficit of $4,720,284. These conditions raise substantial doubt about the Company&#x2019;s ability to continue as a going concern for a period of time within one year after that date that the consolidated financial statements are issued.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The Company&#x2019;s existence is dependent upon management&#x2019;s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that the Company&#x2019;s efforts will be successful. No assurance can be given that management&#x2019;s actions will result in profitable operations or the resolution of its liquidity problems. The accompanying consolidated financial statements do not include any adjustments that might result should the company be unable to continue as a going concern.&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-indent:18pt;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;In order to improve the Company&#x2019;s liquidity, the Company&#x2019;s management is actively pursuing additional equity financing through discussions with investment bankers and private investors. There can be no assurance that the Company will be successful in its effort to secure additional equity financing.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-indent:18pt;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The financial statements do not include any adjustments relating to the recoverability of assets and the amount or classification of liabilities that might be necessary should the Company be unable to continue as a going concern.&lt;/span&gt;&lt;/p&gt;
</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6453"
      unitRef="USD">-418105</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6454"
      unitRef="USD">-36258</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:AssetsCurrent
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6455"
      unitRef="USD">331050</us-gaap:AssetsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6456"
      unitRef="USD">5051334</us-gaap:LiabilitiesCurrent>
    <fil:WorkingCapital
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6457"
      unitRef="USD">4720284</fil:WorkingCapital>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="Y26Q1" id="ixv-3491">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;NOTE 3 &#x2013;&#160;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;text-align:justify"&gt;The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and the applicable rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC. The accompanying condensed financial statements are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company&#x2019;s financial position as of March 31, 2026, and the results of its operations and its cash flows for the three months ended March 31, 2026 and 2025. The balance sheet as of December 31, 2025 is derived from the Company&#x2019;s audited financial statements. The results of operations for the three months ended March 31, 2026 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2026.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, MYC and NPD. All inter-company accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The preparation of financial statements in conformity with U.S GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Our financial statements include, when applicable, disclosures of estimates, assumptions, uncertainties, and markets that could affect our financial statements and future operations.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Cash&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The Company considers all highly liquid investments with original maturities at the date of purchase of three months or less to be cash equivalents. Cash and cash equivalents include bank demand deposits, marketable securities with maturities of three months or less at purchase, and money market funds that invest primarily in certificates of deposits, commercial paper and U.S. government and U.S. government agency obligations. Cash equivalents are reported at fair value. The Company maintains its cash balances with a bank whose balance is insured by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) up to $250,000. The Company monitors the cash balances held in its bank accounts, and as of March 31, 2026, and December 31, 2025, did not have any concerns regarding cash balances which exceeded the insured amounts.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Property and Equipment, Net&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;Property and equipment are stated at cost. For financial reporting, we provide for depreciation using the straight-line method at rates based upon the estimated useful lives of the various assets. Depreciation expense was $0 and $249 for the three months ended March 31, 2026, and 2025, respectively. The Company computes depreciation utilizing estimated useful lives, as stated below:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="background-color:#FFFFFF;width:80%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&lt;b&gt;Property and Equipment, Net Categories&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:2%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:18%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Estimated Useful Life&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Equipment&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;3 Years&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;Management assesses property and equipment for impairment whenever there is an indicator of impairment. Impairment losses are evaluated if the estimated undiscounted cash flows from using the assets are less than carrying value. A loss is recognized when the carrying value of an asset exceeds its fair value. Management assessed and concluded that no impairment write-down would be necessary for the Company&#x2019;s property and equipment as of March 31, 2026 and December 31, 2025.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Finite Long-lived Intangible&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;Assets, Net&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;Finite long-lived intangible assets are recorded at their estimated fair value at the date of acquisition. Finite long-lived intangible assets are amortized on a straight-line basis over their estimated useful lives. Management annually evaluates the estimated remaining useful lives of the finite intangible assets to determine whether events or changes in circumstances warrant a revision to the remaining period of amortization. &lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;Finite long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be fully recoverable. An impairment loss is recognized if the sum of the expected long-term undiscounted cash flows the asset is expected to generate is less than its carrying amount. Any write-downs are treated as permanent reductions in the carrying amount of the respective asset. Management assessed and concluded that no impairment write-down would be necessary for finite long-lived intangible assets as of March 31, 2026, and December 31, 2025.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;The Company amortizes these intangible assets on a straight-line basis over their estimated useful lives, as stated below: &#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="background-color:#FFFFFF;width:80%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&lt;b&gt;Intangible Assets, Net Categories&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:2%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:18%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Estimated Useful Life&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Intellectual property&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;3 Years&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The Company accounts for financial instruments in accordance with ASC 820,&#160;&lt;i&gt;Fair Value Measurements and Disclosures.&lt;/i&gt;&#160;&#160;ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;Level 1 &#x2013;&#160;Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;Level 2 &#x2013;&#160;Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data; &lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;Level 3 &#x2013;&#160;Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;There were no changes in the fair value hierarchy leveling during the three months ended March 31, 2026 and 2025.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The Company provides for income taxes using the asset and liability approach. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. As of March 31, 2026 and December 31, 2025, the Company had a full valuation allowance against its deferred tax assets.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;We adopted ASC 740-10-25, &lt;i&gt;Income Taxes&#x2014;Recognition&lt;/i&gt;, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under ASC 740-10-25, we may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. ASC 740-10-25 also provides guidance on derecognition, classification, interest and penalties on income taxes, and accounting in interim periods and requires increased disclosures. We had no material adjustments to our liabilities for unrecognized income tax benefits according to the provisions of ASC 740-10-25.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Stock Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;We follow ASC 718,&#160;&lt;i&gt;Compensation&#x2013;Stock Compensation,&lt;/i&gt;&#160;which prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Share-based payments to employees and non-employees, including grants of stock options, are recognized as compensation expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Segment Information&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The Company operates as one operating segment with a focus on the development and management of companies and technologies that integrate artificial intelligence (AI) and robotics to enhance innovation and efficiency across multiple industries. The Company focuses on identifying, developing, and scaling businesses that benefit from automation, machine learning, and advanced robotics, driving transformative solutions in healthcare, manufacturing, logistics, and beyond. The Company&#x2019;s Chief Executive Officer, as its chief operating decision maker (CODM), manages and allocates resources to the operations of the Company on a consolidated basis. The CODM assesses performance and allocates resources based on the Company&#x2019;s consolidated statements of operations and key components and processes of the Company&#x2019;s operations are managed centrally. Segment asset information is not used by the CODM to allocate resources. This enables our Chief Executive Officer to assess our overall level of available resources and determine how best to deploy these resources across projects to monitor and evaluate overall company performance, allocating resources, and establishing management compensation in line with our long-term company-wide strategic goals.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Basic and&#160;Diluted&#160;Net&#160;Loss per&#160;Share&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;Basic loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period before giving effect to stock options, stock warrants, restricted stock units and convertible securities outstanding, which are considered to be dilutive common stock equivalents. Diluted net loss per common share is calculated based on the weighted average number of common and potentially dilutive shares outstanding during the period after giving effect to dilutive common stock equivalents. Contingently issuable shares are included in the computation of basic loss per share when issuance of the shares is no longer contingent. &lt;/span&gt;The common stock equivalents not included in the computation of earnings per share because the effect was antidilutive, were related to convertible debt and totaled 1,160,060 and 1,809,200 shares, the convertible preferred stock that totaled 1,995,600 and 0, and the outstanding warrants that totaled 0 and 0 shares for the three months ended March 31, 2026 and 2025, respectively.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Recent&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;ly Issued&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt; Accounting &lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;Standards&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;Management does not believe that any recently issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying consolidated financial statements, other than those disclosed below.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;In November 2024, the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2024-03, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (&#x201c;ASU 2024-03&#x201d;) and in January 2025, the FASB issued ASU No. 2025-01, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03. ASU 2024-03 will require the Company to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization, as applicable, included in certain expense captions in the Consolidated Statements of Operations, as well as qualitatively describe remaining amounts included in those captions. ASU 2024-03 will also require the Company to disclose both the amount and the Company&#x2019;s definition of selling expenses. The Company will adopt ASU 2024-03 in its annual report for the year ended December 31, 2026.&lt;/span&gt;&lt;/p&gt;
</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccounting contextRef="Y26Q1" id="ixv-3498">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;text-align:justify"&gt;The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and the applicable rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC. The accompanying condensed financial statements are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company&#x2019;s financial position as of March 31, 2026, and the results of its operations and its cash flows for the three months ended March 31, 2026 and 2025. The balance sheet as of December 31, 2025 is derived from the Company&#x2019;s audited financial statements. The results of operations for the three months ended March 31, 2026 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2026.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, MYC and NPD. All inter-company accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;
</us-gaap:BasisOfAccounting>
    <us-gaap:UseOfEstimates contextRef="Y26Q1" id="ixv-3509">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The preparation of financial statements in conformity with U.S GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Our financial statements include, when applicable, disclosures of estimates, assumptions, uncertainties, and markets that could affect our financial statements and future operations.&lt;/span&gt;&lt;/p&gt;
</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="Y26Q1" id="ixv-3519">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Cash&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The Company considers all highly liquid investments with original maturities at the date of purchase of three months or less to be cash equivalents. Cash and cash equivalents include bank demand deposits, marketable securities with maturities of three months or less at purchase, and money market funds that invest primarily in certificates of deposits, commercial paper and U.S. government and U.S. government agency obligations. Cash equivalents are reported at fair value. The Company maintains its cash balances with a bank whose balance is insured by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) up to $250,000. The Company monitors the cash balances held in its bank accounts, and as of March 31, 2026, and December 31, 2025, did not have any concerns regarding cash balances which exceeded the insured amounts.&lt;/span&gt;&lt;/p&gt;
</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashFDICInsuredAmount
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6458"
      unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="Y26Q1" id="ixv-3529">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Property and Equipment, Net&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;Property and equipment are stated at cost. For financial reporting, we provide for depreciation using the straight-line method at rates based upon the estimated useful lives of the various assets. Depreciation expense was $0 and $249 for the three months ended March 31, 2026, and 2025, respectively. The Company computes depreciation utilizing estimated useful lives, as stated below:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="background-color:#FFFFFF;width:80%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&lt;b&gt;Property and Equipment, Net Categories&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:2%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:18%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Estimated Useful Life&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Equipment&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;3 Years&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;Management assesses property and equipment for impairment whenever there is an indicator of impairment. Impairment losses are evaluated if the estimated undiscounted cash flows from using the assets are less than carrying value. A loss is recognized when the carrying value of an asset exceeds its fair value. Management assessed and concluded that no impairment write-down would be necessary for the Company&#x2019;s property and equipment as of March 31, 2026 and December 31, 2025.&lt;/span&gt;&lt;/p&gt;
</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:Depreciation
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6459"
      unitRef="USD">0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6460"
      unitRef="USD">249</us-gaap:Depreciation>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="Y26Q1" id="ixv-3539">&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="background-color:#FFFFFF;width:80%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&lt;b&gt;Property and Equipment, Net Categories&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:2%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:18%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Estimated Useful Life&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Equipment&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;3 Years&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="E26Q1_PpeByType-Equipment" id="ixv-6461">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="Y26Q1" id="ixv-3562">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Finite Long-lived Intangible&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;Assets, Net&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;Finite long-lived intangible assets are recorded at their estimated fair value at the date of acquisition. Finite long-lived intangible assets are amortized on a straight-line basis over their estimated useful lives. Management annually evaluates the estimated remaining useful lives of the finite intangible assets to determine whether events or changes in circumstances warrant a revision to the remaining period of amortization. &lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;Finite long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be fully recoverable. An impairment loss is recognized if the sum of the expected long-term undiscounted cash flows the asset is expected to generate is less than its carrying amount. Any write-downs are treated as permanent reductions in the carrying amount of the respective asset. Management assessed and concluded that no impairment write-down would be necessary for finite long-lived intangible assets as of March 31, 2026, and December 31, 2025.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;The Company amortizes these intangible assets on a straight-line basis over their estimated useful lives, as stated below: &#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="background-color:#FFFFFF;width:80%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&lt;b&gt;Intangible Assets, Net Categories&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:2%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:18%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Estimated Useful Life&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Intellectual property&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;3 Years&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock contextRef="Y26Q1" id="ixv-3584">&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="background-color:#FFFFFF;width:80%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&lt;b&gt;Intangible Assets, Net Categories&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:2%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:18%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Estimated Useful Life&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Intellectual property&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;3 Years&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="E26Q1_FiniteLivedIntangibleAssetsByMajorClass-IntellectualProp"
      id="ixv-6462">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="Y26Q1" id="ixv-3605">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The Company accounts for financial instruments in accordance with ASC 820,&#160;&lt;i&gt;Fair Value Measurements and Disclosures.&lt;/i&gt;&#160;&#160;ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;Level 1 &#x2013;&#160;Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;Level 2 &#x2013;&#160;Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data; &lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;Level 3 &#x2013;&#160;Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;There were no changes in the fair value hierarchy leveling during the three months ended March 31, 2026 and 2025.&lt;/span&gt;&lt;/p&gt;
</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="Y26Q1" id="ixv-3631">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The Company provides for income taxes using the asset and liability approach. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. As of March 31, 2026 and December 31, 2025, the Company had a full valuation allowance against its deferred tax assets.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;We adopted ASC 740-10-25, &lt;i&gt;Income Taxes&#x2014;Recognition&lt;/i&gt;, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under ASC 740-10-25, we may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. ASC 740-10-25 also provides guidance on derecognition, classification, interest and penalties on income taxes, and accounting in interim periods and requires increased disclosures. We had no material adjustments to our liabilities for unrecognized income tax benefits according to the provisions of ASC 740-10-25.&lt;/span&gt;&lt;/p&gt;
</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="Y26Q1" id="ixv-3646">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Stock Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;We follow ASC 718,&#160;&lt;i&gt;Compensation&#x2013;Stock Compensation,&lt;/i&gt;&#160;which prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Share-based payments to employees and non-employees, including grants of stock options, are recognized as compensation expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).&lt;/span&gt;&lt;/p&gt;
</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="Y26Q1" id="ixv-3663">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Segment Information&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The Company operates as one operating segment with a focus on the development and management of companies and technologies that integrate artificial intelligence (AI) and robotics to enhance innovation and efficiency across multiple industries. The Company focuses on identifying, developing, and scaling businesses that benefit from automation, machine learning, and advanced robotics, driving transformative solutions in healthcare, manufacturing, logistics, and beyond. The Company&#x2019;s Chief Executive Officer, as its chief operating decision maker (CODM), manages and allocates resources to the operations of the Company on a consolidated basis. The CODM assesses performance and allocates resources based on the Company&#x2019;s consolidated statements of operations and key components and processes of the Company&#x2019;s operations are managed centrally. Segment asset information is not used by the CODM to allocate resources. This enables our Chief Executive Officer to assess our overall level of available resources and determine how best to deploy these resources across projects to monitor and evaluate overall company performance, allocating resources, and establishing management compensation in line with our long-term company-wide strategic goals.&lt;/span&gt;&lt;/p&gt;
</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="Y26Q1" id="ixv-3672">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Basic and&#160;Diluted&#160;Net&#160;Loss per&#160;Share&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;Basic loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period before giving effect to stock options, stock warrants, restricted stock units and convertible securities outstanding, which are considered to be dilutive common stock equivalents. Diluted net loss per common share is calculated based on the weighted average number of common and potentially dilutive shares outstanding during the period after giving effect to dilutive common stock equivalents. Contingently issuable shares are included in the computation of basic loss per share when issuance of the shares is no longer contingent. &lt;/span&gt;The common stock equivalents not included in the computation of earnings per share because the effect was antidilutive, were related to convertible debt and totaled 1,160,060 and 1,809,200 shares, the convertible preferred stock that totaled 1,995,600 and 0, and the outstanding warrants that totaled 0 and 0 shares for the three months ended March 31, 2026 and 2025, respectively.&lt;/p&gt;
</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Y26Q1_DebtInstr-ConvertibleDebt1"
      decimals="INF"
      id="ixv-6463"
      unitRef="Shares">1160060</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Y25Q1_DebtInstr-ConvertibleDebt1"
      decimals="INF"
      id="ixv-6464"
      unitRef="Shares">1809200</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <fil:ShareholderLoan
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6465"
      unitRef="USD">1995600</fil:ShareholderLoan>
    <fil:ShareholderLoan contextRef="E25" decimals="INF" id="ixv-6466" unitRef="USD">1995600</fil:ShareholderLoan>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Y26Q1_DebtInstr-Warrants"
      decimals="INF"
      id="ixv-6467"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Y25Q1_DebtInstr-Warrants"
      decimals="INF"
      id="ixv-6468"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="Y26Q1" id="ixv-3682">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Recent&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;ly Issued&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt; Accounting &lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;Standards&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;Management does not believe that any recently issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying consolidated financial statements, other than those disclosed below.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;In November 2024, the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2024-03, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (&#x201c;ASU 2024-03&#x201d;) and in January 2025, the FASB issued ASU No. 2025-01, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03. ASU 2024-03 will require the Company to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization, as applicable, included in certain expense captions in the Consolidated Statements of Operations, as well as qualitatively describe remaining amounts included in those captions. ASU 2024-03 will also require the Company to disclose both the amount and the Company&#x2019;s definition of selling expenses. The Company will adopt ASU 2024-03 in its annual report for the year ended December 31, 2026.&lt;/span&gt;&lt;/p&gt;
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:AssetAcquisitionTextBlock contextRef="Y26Q1" id="ixv-3703">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;NOTE 4 &#x2013;&#160;ASSETS &lt;/b&gt;&lt;b&gt;ACQUISITION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;On November 28, 2023, the Company entered into an asset sale and purchase agreement with Philon Labs, LLC. (the &#x201c;seller&#x201d; or &#x201c;Philon Labs&#x201d;) for consideration of approximately $2,000,000 in exchange for the intangible assets. The purpose of the assets purchase was to begin the Company&#x2019;s transition to a growth-oriented company that applies advanced engineering and design techniques to new products. The entire purchase consideration was allocated as fair value to the intellectual property acquired from the seller. The $2,000,000 was to be paid through the issuance of a new series of Preferred Stock. As of March 31, 2026, the consideration has not been issued to the seller and is recorded as shares to be issued on the consolidated balance sheet. The Company has analyzed the shares to be issued balance and determined that they are liabilities in accordance with &lt;i&gt;ASC 480 &#x2013;&#160;Distinguishing Liabilities from Equity&lt;/i&gt;. No shares were issued during the three months ending March 31, 2026. &lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;The acquired intangible assets are being amortized over their estimated useful lives of 3 years.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;Intangible assets as of March 31, 2026 and December 31, 2025, are as follows:&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:99.16%"&gt;&lt;tr style="height:7.2pt"&gt;&lt;td style="width:49.86%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:24.38%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.7%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="3" style="width:23.06%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.2pt"&gt;&lt;td style="width:49.86%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:24.38%;padding:0.75pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.7%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="3" style="width:23.06%;padding:0.75pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.2pt"&gt;&lt;td style="background-color:#CCEEFF;width:49.86%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;Intellectual property&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.34%;padding:0.75pt;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:22.04%;padding:0.75pt;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;2,000,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.7%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.7%;padding:0.75pt;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:18.14%;padding:0.75pt;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;2,000,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.22%;padding:0.75pt;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.2pt"&gt;&lt;td style="width:49.86%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;Less: accumulated amortization&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.34%;padding:0.75pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:22.04%;padding:0.75pt;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;(1,559,817&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.7%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;)&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.7%;padding:0.75pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:18.14%;padding:0.75pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;(1,395,434&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.22%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;)&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.2pt"&gt;&lt;td style="background-color:#CCEEFF;width:49.86%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;Intangible assets, net&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.34%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:22.04%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;440,183&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.7%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.7%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:18.14%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;604,566&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.22%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;Amortization expense from intangible assets was $169,956 and $164,234 for the three months ended March 31, 2026, and 2025. &lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;Future amortization expense from intangible assets as of March 31, 2026, were as follows:&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="background-color:#D3F0FE;width:77.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Remainder of 2026&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:1.06%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:17.98%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;440,183&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#FFFFFF;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Thereafter&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;padding-bottom:2.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Total remaining amortization expense&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;padding-bottom:2.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;440,183&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;padding-bottom:2.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
</us-gaap:AssetAcquisitionTextBlock>
    <fil:IntangibleAssetsAcquiredThroughPromiseToIssueShares
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6469"
      unitRef="USD">2000000</fil:IntangibleAssetsAcquiredThroughPromiseToIssueShares>
    <us-gaap:AssetAcquisitionTableTextBlock contextRef="Y26Q1" id="ixv-3723">&lt;table style="border-collapse:collapse;width:99.16%"&gt;&lt;tr style="height:7.2pt"&gt;&lt;td style="width:49.86%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:24.38%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.7%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="3" style="width:23.06%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.2pt"&gt;&lt;td style="width:49.86%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:24.38%;padding:0.75pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.7%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="3" style="width:23.06%;padding:0.75pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.2pt"&gt;&lt;td style="background-color:#CCEEFF;width:49.86%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;Intellectual property&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.34%;padding:0.75pt;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:22.04%;padding:0.75pt;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;2,000,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.7%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.7%;padding:0.75pt;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:18.14%;padding:0.75pt;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;2,000,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.22%;padding:0.75pt;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.2pt"&gt;&lt;td style="width:49.86%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;Less: accumulated amortization&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.34%;padding:0.75pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:22.04%;padding:0.75pt;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;(1,559,817&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.7%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;)&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.7%;padding:0.75pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:18.14%;padding:0.75pt;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;(1,395,434&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.22%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;)&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.2pt"&gt;&lt;td style="background-color:#CCEEFF;width:49.86%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;Intangible assets, net&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.34%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:22.04%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;440,183&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.7%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.7%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:18.14%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;604,566&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.22%;padding:0.75pt" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:AssetAcquisitionTableTextBlock>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="E26Q1_FiniteLivedIntangibleAssetsByMajorClass-IntellectualProp"
      decimals="INF"
      id="ixv-6470"
      unitRef="USD">2000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="E25_FiniteLivedIntangibleAssetsByMajorClass-IntellectualProp"
      decimals="INF"
      id="ixv-6471"
      unitRef="USD">2000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6472"
      unitRef="USD">1559817</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="E25" decimals="INF" id="ixv-6473" unitRef="USD">1395434</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6474"
      unitRef="USD">440183</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="E25" decimals="INF" id="ixv-6475" unitRef="USD">604566</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:AdjustmentForAmortization
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6476"
      unitRef="USD">169956</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6477"
      unitRef="USD">164234</us-gaap:AdjustmentForAmortization>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="Y26Q1" id="ixv-3803">&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="background-color:#D3F0FE;width:77.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Remainder of 2026&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:1.06%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:17.98%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;440,183&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#FFFFFF;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Thereafter&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;padding-bottom:2.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Total remaining amortization expense&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;padding-bottom:2.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;440,183&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;padding-bottom:2.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6478"
      unitRef="USD">440183</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6479"
      unitRef="USD">440183</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="Y26Q1" id="ixv-3842">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;NOTE&#160;&lt;/b&gt;&lt;b&gt;5&lt;/b&gt;&lt;b&gt;&#160;&#x2013;&#160;RELATED PARTY TRANSACTION&lt;/b&gt;&lt;b&gt;S&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Notes Payable &#x2013;&#160;Related Parties&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;On January 30, 2024, the Company signed an agreement with a major shareholder for a $165,000 note payable. The note accrues interest at a rate of 1.75% compounded annually (Note 6 &#x2013;&#160;Promissory and Convertible Notes). The note had interest expense of $712 and $712 for the three months ended March 31, 2026 and March 31, 2025, respectively. As of March 31, 2026, the Company had recorded accrued interest of $6,258 related to the note within accrued interest on the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;AIBiotics Consulting Agreement with the CEO&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;On November 17, 2021, AIBiotics entered into an Executive Consulting Agreement (the &#x201c;AIBiotics Consulting Agreement&#x201d;), with Benjamin Kaplan (&#x201c;BK&#x201d;) to serve as the Company&#x2019;s CEO for an initial term of 36 months. As of March 31, 2026 and December 31, 2025, the Company had cash compensation outstanding as accrued expense - related party due to the AIBiotics Consulting Agreement of $248,281 and $216,734, respectively. During the three months ended March 31, 2026 and 2025, the Company recognized stock-based compensation of $0 and $0, respectively, from Warrants issued in connection with the AIBiotics Consulting Agreement. &#160;The Company records stock-based compensation on the consolidated income statement as general and administrative expense. &lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;Significant terms of the AIBiotics Consulting Agreement are as follows:&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="border-bottom:1px solid #000000"&gt;Annual Base Consulting Fee&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;Every calendar month the Company pays the CEO a consulting fee of $24,000, with an annual total fee of $288,000. &lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="border-bottom:1px solid #000000"&gt;Bonus Compensation Milestones &lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The Company will pay the CEO a bonus in AIBiotics restricted stock or restricted stock units based on the following EBITDA milestones. As of March 31, 2026, no EBITDA milestones were met, and no amounts have been recorded for the bonus milestones.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td colspan="2" style="width:29.88%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;Bonus &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.98%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.98%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:66.16%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;EBITDA Milestones &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:3.98%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:25.88%;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;100,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:66.16%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;1&lt;span style="vertical-align:super"&gt;st&#160;&lt;/span&gt;$1,000,000&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:3.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:25.88%" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;100,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:66.16%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;2&lt;span style="vertical-align:super"&gt;nd&#160;&lt;/span&gt;$1,000,000&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:3.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:25.88%" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;100,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:66.16%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;3&lt;span style="vertical-align:super"&gt;rd&#160;&lt;/span&gt;$1,000,000&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:3.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:25.88%" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;100,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:66.16%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;4&lt;span style="vertical-align:super"&gt;th&#160;&lt;/span&gt;$1,000,000&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:3.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:25.88%" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;100,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:66.16%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;5&lt;span style="vertical-align:super"&gt;th&#160;&lt;/span&gt;$1,000,000&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The Company will pay the CEO a bonus in restricted stock or restricted stock units based on the following AIBiotics market capitalization by maintaining the below market cap for AIBiotics for a period of 22 consecutive trading days:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="width:30.88%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;Bonus (Shares)&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:65.36%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;Market Capitalization Milestone &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:30.88%;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;250,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.12%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:63.26%;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;30,000,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:30.88%" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;250,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.12%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:63.26%" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;40,000,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:30.88%" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;250,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.12%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:63.26%" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;60,000,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:30.88%" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;250,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.12%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:63.26%" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;80,000,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:30.88%" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;250,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.12%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:63.26%" valign="middle"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;100,000,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;i&gt;Stock Grants &#x2013;&#160;Significant Transactions&lt;/i&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;Upon the Company closing a Significant Transaction, the CEO shall be granted shares of AIBiotics common stock or a new series of AIBiotics preferred shares that is convertible into AIBiotics common stock equal to 5% of the value of all the consideration, including any stock, cash or debt of such completed transaction. A &#x201c;Significant Transaction&#x201d; shall mean a financing of at least $500,000 or the closing of an acquisition with a valuation of at least $1,000,000 for AIBiotics. As of March 31, 2026 and December 31, 2025, the Company had not granted any shares in relation to a Significant Transaction.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;As of March 31, 2026 and December 31, 2025, there are no amounts accrued related to the bonuses.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Board Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;As of March 31, 2026 and December 31, 2025, the Company had accrued expenses from board compensation of $310,000 and $270,000, respectively. Accrued board compensation is included as part of Accounts payable and accrued expenses on the consolidated balance sheets.&lt;/p&gt;
</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <fil:DueToRelatedParties
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6480"
      unitRef="USD">165000</fil:DueToRelatedParties>
    <us-gaap:InterestExpenseDebt
      contextRef="Y26Q1_RelPtyTrnsByRelPty-MajorShareholder"
      decimals="INF"
      id="ixv-6481"
      unitRef="USD">712</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="Y25Q1_RelPtyTrnsByRelPty-MajorShareholder"
      decimals="INF"
      id="ixv-6482"
      unitRef="USD">712</us-gaap:InterestExpenseDebt>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="E26Q1_RelPtyTrnsByRelPty-MajorShareholder"
      decimals="INF"
      id="ixv-6483"
      unitRef="USD">6258</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6484"
      unitRef="USD">248281</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="E25" decimals="INF" id="ixv-6485" unitRef="USD">216734</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:ShareBasedCompensation
      contextRef="Y26Q1_RelPtyTrnsByRelPty-Ceo"
      decimals="INF"
      id="ixv-6486"
      unitRef="USD">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="Y25Q1_RelPtyTrnsByRelPty-Ceo"
      decimals="INF"
      id="ixv-6487"
      unitRef="USD">0</us-gaap:ShareBasedCompensation>
    <fil:ConsultingFee
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6488"
      unitRef="USD">288000</fil:ConsultingFee>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="E26Q1_RelPtyTrnsByRelPty-BoardCompensation"
      decimals="INF"
      id="ixv-6489"
      unitRef="USD">310000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="E25_RelPtyTrnsByRelPty-BoardCompensation"
      decimals="INF"
      id="ixv-6490"
      unitRef="USD">270000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="Y26Q1" id="ixv-4051">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;NOTE&#160;&lt;/b&gt;&lt;b&gt;6&lt;/b&gt;&lt;b&gt;&#160;&#x2013;&#160;PROMISSORY AND CONVERTIBLE NOTES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;On August 27, 2021, the Company issued a lender (&#x201c;Lender A&#x201d;) a convertible note payable with principal of $500,000 and an original issue discount of $50,000. The note matures after 24 months and has an effective interest rate of 8%. As of March 31, 2026 and December 31, 2025, this convertible note payable was in default and therefore classified as a current liability. Default interest accrues at a rate of 20% upon default, and the default conversion price is $0.75 per share. During the year ended December 31, 2024, the Company converted $110,000 of accrued interest into 2,200,000 shares of common stock pursuant to the terms of the convertible note agreement. Although the conversion was effective as of December 31, 2024, the related shares were issued in January 2025. The fair value of the shares issued was $44,000 and was recorded within the statement of stockholders&#x2019; equity for the year ended December 31, 2025.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;On April 22, 2025, Lender A (&#x201c;the Seller&#x201d;) entered into a note assignment and purchase agreement with a buyer (&#x201c;Lender G&#x201d;) whereas the Seller agreed to sell, assign, transfer, and convey the Note, including the unpaid principal and accrued and unpaid interest thereon to the Buyer.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;During the year ended December 31, 2025, the Company converted $150,438 of accrued interest into shares of the Company&#x2019;s common stock. Lender A received 54,079,852 common shares, with a fair value of $179,896 which is recorded within the statement of stockholder equity.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;On September 17, 2021, the Company issued a lender (&#x201c;Lender B&#x201d;) a convertible note payable with principal of $55,000 and an original issue discount of $5,000. The note matures after 24 months and has an effective interest rate of 8%. As of March 31, 2026, and December 31, 2025, this convertible note payable was in default and therefore classified as a current liability. Default interest accrues at a rate of 20% upon default, and the default conversion price is $0.75 per share. As of March 31, 2026, and December 31, 2025, the Company had an outstanding principal amount of $55,000 due to this lender as a result of the note.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;On October 27, 2021, the Company issued a lender (&#x201c;Lender C&#x201d;) a convertible note payable with principal of $220,000 and an original issue discount of $20,000. The note matures after 24 months and has an effective interest rate of 8%. During 2025, the note was assigned to Lender G. As of March 31, 2026, no balance remains outstanding under this note as a result of prior conversions of both principal and accrued interest completed during the year ended December 31, 2025.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;On January 21, 2022, the Company issued a convertible note payable to a lender (&#x201c;Lender E&#x201d;) with a principal balance of $325,000 and an original issue discount of $75,000. As of March 31, 2026, the outstanding principal balance was $325,000 with accrued interest of $209,487, for a total outstanding balance of $534,487. The note is currently in default and classified as a current liability. Default interest accrues at 20% per annum, and the default conversion price is $0.975 per share.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;On January 30, 2024, the Company entered into a note payable agreement with a related party (&#x201c;Lender F&#x201d;) for $165,000. The note bears interest at 1.75% compounded annually. As of March 31, 2026, the outstanding principal balance was $165,000 with accrued interest of $6,258, for a total outstanding balance of $171,258.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;On May 6, 2025, the Company issued a convertible note payable to a lender (&#x201c;Lender G&#x201d;) with a principal balance of $275,000 and an original issue discount of $25,000. As of March 31, 2026, the outstanding principal balance was $261,267 with accrued interest of $24,788, for a total outstanding balance of $286,055. The note bears interest at 10% per annum and matures in May 2027.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;On September 12, 2025, the Company issued a promissory note (&#x201c;Lender H&#x201d;) with an original principal balance of $58,823 and an original issue discount of $8,823, resulting in proceeds of $50,000. The note bears interest at 12% per annum and matured on January 2, 2026. As of March 31, 2026, the outstanding principal balance was approximately $5,000 with accrued interest of approximately $3,868, for a total outstanding balance of $8,868.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;In March 2026, the Company entered into a convertible note agreement with a lender (&#x201c;Lender I&#x201d;) pursuant to which it issued a note with a principal balance of $93,750 in exchange for proceeds of $75,000, reflecting an original issue discount. As of March 31, 2026, the outstanding principal balance was $75,334 with accrued interest of $334, for a total outstanding balance of $93,750. The note bears interest at 10% per annum and matures in March 2028.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;The following tables reflects a summary of the outstanding principal and interest by each lender and their respective maturity date as of March 31, 2026 and December 31, 2025:&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="5" style="width:36.86%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;March 31, 2026&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="5" style="width:40.74%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;December 31, 2025&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Maturity Date&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Total Outstanding***&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.9%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Principal&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.28%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Total Outstanding***&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.12%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Principal&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.92%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="background-color:#D3F0FE;width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender &lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;G (formerly Lender &lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;A&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;8/27/2024&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;495,572&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;471,417&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;24,155&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;471,417&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;471,417&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender B&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;9/27/2024&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;66,115&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;55,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;11,115&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;63,403&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;55,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;8,403&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="background-color:#D3F0FE;width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender D&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;10/21/2024&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;(33,851)&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;2,407&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;2,407&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender E&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;01/21/2024&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;534,487&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;325,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;209,487&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;515,407&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;325,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;190,407&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="background-color:#D3F0FE;width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender F&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;01/30/2025&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;171,258&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;165,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;6,258&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;170,546&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;165,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;5,546&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender G&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;05/06/2027&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;286,055&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;261,267&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;24,788&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;266,029&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;258,185&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;7,844&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="background-color:#D3F0FE;width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender H&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;01/02/2026&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;8,868&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;5,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;3,868&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;10,794&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;8,667&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;2,127&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender I&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;03/17/2028&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;93,750&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;75,334&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;334&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:14.05pt"&gt;&lt;td style="background-color:#D3F0FE;width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0"&gt;&lt;span style="font-size:8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;1,656,104&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.9%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;1,358,018&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.28%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;246,154&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;1,500,003&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:12.12%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;1,283,269&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:10.92%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;216,734&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="11" style="width:79.7%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&lt;b&gt;&lt;i&gt;*** - Total Outstanding = Principal + Interest as of March 31, 2026 and December 31, 2025&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;During the three months ended March 31, 2026 and 2025, the Company recorded debt discount amortization expense in the amount of $5,573 and $0, respectively. As of March 31, 2026, the Company had an unamortized debt discount balance of $25,216.&lt;/p&gt;
</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ShortTermDebtDescription contextRef="Y26Q1_ShortTermDebtType-LenderA" id="ixv-6491">On August 27, 2021, the Company issued a lender (&#x201c;Lender A&#x201d;) a convertible note payable with principal of $500,000 and an original issue discount of $50,000. The note matures after 24 months and has an effective interest rate of 8%. As of March 31, 2026 and December 31, 2025, this convertible note payable was in default and therefore classified as a current liability. Default interest accrues at a rate of 20% upon default, and the default conversion price is $0.75 per share. During the year ended December 31, 2024, the Company converted $110,000 of accrued interest into 2,200,000 shares of common stock pursuant to the terms of the convertible note agreement. Although the conversion was effective as of December 31, 2024, the related shares were issued in January 2025. The fair value of the shares issued was $44,000 and was recorded within the statement of stockholders&#x2019; equity for the year ended December 31, 2025.</us-gaap:ShortTermDebtDescription>
    <us-gaap:ShortTermDebtDescription
      contextRef="D250422_ShortTermDebtType-LenderGFormerlyLenderA"
      id="ixv-6492">On April 22, 2025, Lender A (&#x201c;the Seller&#x201d;) entered into a note assignment and purchase agreement with a buyer (&#x201c;Lender G&#x201d;) whereas the Seller agreed to sell, assign, transfer, and convey the Note, including the unpaid principal and accrued and unpaid interest thereon to the Buyer.</us-gaap:ShortTermDebtDescription>
    <us-gaap:ShortTermDebtDescription
      contextRef="Y26Q1_ShortTermDebtType-LenderGFormerlyLenderA"
      id="ixv-6493">During the year ended December 31, 2025, the Company converted $150,438 of accrued interest into shares of the Company&#x2019;s common stock. Lender A received 54,079,852 common shares, with a fair value of $179,896 which is recorded within the statement of stockholder equity.</us-gaap:ShortTermDebtDescription>
    <us-gaap:ShortTermDebtDescription contextRef="Y26Q1_ShortTermDebtType-LenderB" id="ixv-6494">On September 17, 2021, the Company issued a lender (&#x201c;Lender B&#x201d;) a convertible note payable with principal of $55,000 and an original issue discount of $5,000. The note matures after 24 months and has an effective interest rate of 8%. As of March 31, 2026, and December 31, 2025, this convertible note payable was in default and therefore classified as a current liability. Default interest accrues at a rate of 20% upon default, and the default conversion price is $0.75 per share. As of March 31, 2026, and December 31, 2025, the Company had an outstanding principal amount of $55,000 due to this lender as a result of the note.</us-gaap:ShortTermDebtDescription>
    <us-gaap:ShortTermDebtDescription contextRef="Y26Q1_ShortTermDebtType-LenderC" id="ixv-6495">On October 27, 2021, the Company issued a lender (&#x201c;Lender C&#x201d;) a convertible note payable with principal of $220,000 and an original issue discount of $20,000. The note matures after 24 months and has an effective interest rate of 8%. During 2025, the note was assigned to Lender G. As of March 31, 2026, no balance remains outstanding under this note as a result of prior conversions of both principal and accrued interest completed during the year ended December 31, 2025.</us-gaap:ShortTermDebtDescription>
    <us-gaap:ShortTermDebtDescription contextRef="Y26Q1_ShortTermDebtType-LenderE" id="ixv-6496">On January 21, 2022, the Company issued a convertible note payable to a lender (&#x201c;Lender E&#x201d;) with a principal balance of $325,000 and an original issue discount of $75,000. As of March 31, 2026, the outstanding principal balance was $325,000 with accrued interest of $209,487, for a total outstanding balance of $534,487. The note is currently in default and classified as a current liability. Default interest accrues at 20% per annum, and the default conversion price is $0.975 per share.</us-gaap:ShortTermDebtDescription>
    <us-gaap:ShortTermDebtDescription contextRef="Y26Q1_ShortTermDebtType-LenderF" id="ixv-6497">On January 30, 2024, the Company entered into a note payable agreement with a related party (&#x201c;Lender F&#x201d;) for $165,000. The note bears interest at 1.75% compounded annually. As of March 31, 2026, the outstanding principal balance was $165,000 with accrued interest of $6,258, for a total outstanding balance of $171,258.</us-gaap:ShortTermDebtDescription>
    <us-gaap:ShortTermDebtDescription contextRef="Y26Q1_ShortTermDebtType-LenderG" id="ixv-6498">On May 6, 2025, the Company issued a convertible note payable to a lender (&#x201c;Lender G&#x201d;) with a principal balance of $275,000 and an original issue discount of $25,000. As of March 31, 2026, the outstanding principal balance was $261,267 with accrued interest of $24,788, for a total outstanding balance of $286,055. The note bears interest at 10% per annum and matures in May 2027.</us-gaap:ShortTermDebtDescription>
    <us-gaap:ShortTermDebtDescription contextRef="Y26Q1_ShortTermDebtType-LenderH" id="ixv-6499">On September 12, 2025, the Company issued a promissory note (&#x201c;Lender H&#x201d;) with an original principal balance of $58,823 and an original issue discount of $8,823, resulting in proceeds of $50,000. The note bears interest at 12% per annum and matured on January 2, 2026. As of March 31, 2026, the outstanding principal balance was approximately $5,000 with accrued interest of approximately $3,868, for a total outstanding balance of $8,868.</us-gaap:ShortTermDebtDescription>
    <us-gaap:ShortTermDebtDescription contextRef="Y26Q1_ShortTermDebtType-LenderI" id="ixv-6500">In March 2026, the Company entered into a convertible note agreement with a lender (&#x201c;Lender I&#x201d;) pursuant to which it issued a note with a principal balance of $93,750 in exchange for proceeds of $75,000, reflecting an original issue discount. As of March 31, 2026, the outstanding principal balance was $75,334 with accrued interest of $334, for a total outstanding balance of $93,750. The note bears interest at 10% per annum and matures in March 2028.</us-gaap:ShortTermDebtDescription>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="Y26Q1" id="ixv-4085">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="5" style="width:36.86%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;March 31, 2026&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="5" style="width:40.74%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;December 31, 2025&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Maturity Date&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Total Outstanding***&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.9%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Principal&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.28%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Total Outstanding***&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.12%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Principal&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.92%;padding:0.75pt;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="background-color:#D3F0FE;width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender &lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;G (formerly Lender &lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;A&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;8/27/2024&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;495,572&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;471,417&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;24,155&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;471,417&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;471,417&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender B&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;9/27/2024&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;66,115&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;55,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;11,115&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;63,403&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;55,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;8,403&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="background-color:#D3F0FE;width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender D&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;10/21/2024&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;(33,851)&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;2,407&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;2,407&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender E&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;01/21/2024&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;534,487&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;325,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;209,487&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;515,407&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;325,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;190,407&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="background-color:#D3F0FE;width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender F&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;01/30/2025&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;171,258&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;165,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;6,258&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;170,546&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;165,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;5,546&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender G&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;05/06/2027&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;286,055&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;261,267&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;24,788&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;266,029&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;258,185&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;7,844&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="background-color:#D3F0FE;width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender H&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;01/02/2026&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;8,868&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;5,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;3,868&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;10,794&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;8,667&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;2,127&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender I&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:center"&gt;03/17/2028&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;93,750&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;75,334&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;334&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:14.05pt"&gt;&lt;td style="background-color:#D3F0FE;width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0"&gt;&lt;span style="font-size:8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;1,656,104&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.9%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;1,358,018&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:9.28%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;246,154&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:13.5%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;1,500,003&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:12.12%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;1,283,269&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#D3F0FE;width:10.92%;padding:0.75pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;216,734&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.9%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.28%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.5%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:12.12%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.1%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.92%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="height:7.05pt"&gt;&lt;td style="width:7.38%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.06%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.78%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.08%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="11" style="width:79.7%;padding:0.75pt" valign="bottom"&gt;&lt;p style="font:8pt Times New Roman;margin:0;color:#000000"&gt;&lt;b&gt;&lt;i&gt;*** - Total Outstanding = Principal + Interest as of March 31, 2026 and December 31, 2025&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="Y26Q1_ShortTermDebtType-LenderGFormerlyLenderA"
      id="ixv-6501">2024-08-27</us-gaap:DebtInstrumentMaturityDate>
    <fil:ConvertibleDebtOutstanding
      contextRef="E26Q1_ShortTermDebtType-LenderGFormerlyLenderA"
      decimals="INF"
      id="ixv-6502"
      unitRef="USD">495572</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E26Q1_ShortTermDebtType-LenderGFormerlyLenderA"
      decimals="INF"
      id="ixv-6503"
      unitRef="USD">471417</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E26Q1_ShortTermDebtType-LenderGFormerlyLenderA"
      decimals="INF"
      id="ixv-6504"
      unitRef="USD">24155</fil:ConvertibleDebtInterest>
    <fil:ConvertibleDebtOutstanding
      contextRef="E25_ShortTermDebtType-LenderGFormerlyLenderA"
      decimals="INF"
      id="ixv-6505"
      unitRef="USD">471417</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E25_ShortTermDebtType-LenderGFormerlyLenderA"
      decimals="INF"
      id="ixv-6506"
      unitRef="USD">471417</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E25_ShortTermDebtType-LenderGFormerlyLenderA"
      decimals="128"
      id="ixv-6507"
      unitRef="USD">0</fil:ConvertibleDebtInterest>
    <us-gaap:DebtInstrumentMaturityDate contextRef="Y26Q1_ShortTermDebtType-LenderB" id="ixv-6508">2024-09-27</us-gaap:DebtInstrumentMaturityDate>
    <fil:ConvertibleDebtOutstanding
      contextRef="E26Q1_ShortTermDebtType-LenderB"
      decimals="INF"
      id="ixv-6509"
      unitRef="USD">66115</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E26Q1_ShortTermDebtType-LenderB"
      decimals="INF"
      id="ixv-6510"
      unitRef="USD">55000</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E26Q1_ShortTermDebtType-LenderB"
      decimals="INF"
      id="ixv-6511"
      unitRef="USD">11115</fil:ConvertibleDebtInterest>
    <fil:ConvertibleDebtOutstanding
      contextRef="E25_ShortTermDebtType-LenderB"
      decimals="INF"
      id="ixv-6512"
      unitRef="USD">63403</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E25_ShortTermDebtType-LenderB"
      decimals="INF"
      id="ixv-6513"
      unitRef="USD">55000</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E25_ShortTermDebtType-LenderB"
      decimals="INF"
      id="ixv-6514"
      unitRef="USD">8403</fil:ConvertibleDebtInterest>
    <us-gaap:DebtInstrumentMaturityDate contextRef="Y26Q1_ShortTermDebtType-LenderD" id="ixv-6515">2024-10-21</us-gaap:DebtInstrumentMaturityDate>
    <fil:ConvertibleDebtOutstanding
      contextRef="E26Q1_ShortTermDebtType-LenderD"
      decimals="128"
      id="ixv-6516"
      unitRef="USD">0</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E26Q1_ShortTermDebtType-LenderD"
      decimals="128"
      id="ixv-6517"
      unitRef="USD">0</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E26Q1_ShortTermDebtType-LenderD"
      decimals="INF"
      id="ixv-6518"
      unitRef="USD">-33851</fil:ConvertibleDebtInterest>
    <fil:ConvertibleDebtOutstanding
      contextRef="E25_ShortTermDebtType-LenderD"
      decimals="INF"
      id="ixv-6519"
      unitRef="USD">2407</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E25_ShortTermDebtType-LenderD"
      decimals="128"
      id="ixv-6520"
      unitRef="USD">0</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E25_ShortTermDebtType-LenderD"
      decimals="INF"
      id="ixv-6521"
      unitRef="USD">2407</fil:ConvertibleDebtInterest>
    <us-gaap:DebtInstrumentMaturityDate contextRef="Y26Q1_ShortTermDebtType-LenderE" id="ixv-6522">2024-01-21</us-gaap:DebtInstrumentMaturityDate>
    <fil:ConvertibleDebtOutstanding
      contextRef="E26Q1_ShortTermDebtType-LenderE"
      decimals="INF"
      id="ixv-6523"
      unitRef="USD">534487</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E26Q1_ShortTermDebtType-LenderE"
      decimals="INF"
      id="ixv-6524"
      unitRef="USD">325000</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E26Q1_ShortTermDebtType-LenderE"
      decimals="INF"
      id="ixv-6525"
      unitRef="USD">209487</fil:ConvertibleDebtInterest>
    <fil:ConvertibleDebtOutstanding
      contextRef="E25_ShortTermDebtType-LenderE"
      decimals="INF"
      id="ixv-6526"
      unitRef="USD">515407</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E25_ShortTermDebtType-LenderE"
      decimals="INF"
      id="ixv-6527"
      unitRef="USD">325000</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E25_ShortTermDebtType-LenderE"
      decimals="INF"
      id="ixv-6528"
      unitRef="USD">190407</fil:ConvertibleDebtInterest>
    <us-gaap:DebtInstrumentMaturityDate contextRef="Y26Q1_ShortTermDebtType-LenderF" id="ixv-6529">2025-01-30</us-gaap:DebtInstrumentMaturityDate>
    <fil:ConvertibleDebtOutstanding
      contextRef="E26Q1_ShortTermDebtType-LenderF"
      decimals="INF"
      id="ixv-6530"
      unitRef="USD">171258</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E26Q1_ShortTermDebtType-LenderF"
      decimals="INF"
      id="ixv-6531"
      unitRef="USD">165000</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E26Q1_ShortTermDebtType-LenderF"
      decimals="INF"
      id="ixv-6532"
      unitRef="USD">6258</fil:ConvertibleDebtInterest>
    <fil:ConvertibleDebtOutstanding
      contextRef="E25_ShortTermDebtType-LenderF"
      decimals="INF"
      id="ixv-6533"
      unitRef="USD">170546</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E25_ShortTermDebtType-LenderF"
      decimals="INF"
      id="ixv-6534"
      unitRef="USD">165000</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E25_ShortTermDebtType-LenderF"
      decimals="INF"
      id="ixv-6535"
      unitRef="USD">5546</fil:ConvertibleDebtInterest>
    <us-gaap:DebtInstrumentMaturityDate contextRef="Y26Q1_ShortTermDebtType-LenderG" id="ixv-6536">2027-05-06</us-gaap:DebtInstrumentMaturityDate>
    <fil:ConvertibleDebtOutstanding
      contextRef="E26Q1_ShortTermDebtType-LenderG"
      decimals="INF"
      id="ixv-6537"
      unitRef="USD">286055</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E26Q1_ShortTermDebtType-LenderG"
      decimals="INF"
      id="ixv-6538"
      unitRef="USD">261267</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E26Q1_ShortTermDebtType-LenderG"
      decimals="INF"
      id="ixv-6539"
      unitRef="USD">24788</fil:ConvertibleDebtInterest>
    <fil:ConvertibleDebtOutstanding
      contextRef="E25_ShortTermDebtType-LenderG"
      decimals="INF"
      id="ixv-6540"
      unitRef="USD">266029</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E25_ShortTermDebtType-LenderG"
      decimals="INF"
      id="ixv-6541"
      unitRef="USD">258185</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E25_ShortTermDebtType-LenderG"
      decimals="INF"
      id="ixv-6542"
      unitRef="USD">7844</fil:ConvertibleDebtInterest>
    <us-gaap:DebtInstrumentMaturityDate contextRef="Y26Q1_ShortTermDebtType-LenderH" id="ixv-6543">2026-01-02</us-gaap:DebtInstrumentMaturityDate>
    <fil:ConvertibleDebtOutstanding
      contextRef="E26Q1_ShortTermDebtType-LenderH"
      decimals="INF"
      id="ixv-6544"
      unitRef="USD">8868</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E26Q1_ShortTermDebtType-LenderH"
      decimals="INF"
      id="ixv-6545"
      unitRef="USD">5000</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E26Q1_ShortTermDebtType-LenderH"
      decimals="INF"
      id="ixv-6546"
      unitRef="USD">3868</fil:ConvertibleDebtInterest>
    <fil:ConvertibleDebtOutstanding
      contextRef="E25_ShortTermDebtType-LenderH"
      decimals="INF"
      id="ixv-6547"
      unitRef="USD">10794</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E25_ShortTermDebtType-LenderH"
      decimals="INF"
      id="ixv-6548"
      unitRef="USD">8667</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E25_ShortTermDebtType-LenderH"
      decimals="INF"
      id="ixv-6549"
      unitRef="USD">2127</fil:ConvertibleDebtInterest>
    <us-gaap:DebtInstrumentMaturityDate contextRef="Y26Q1_ShortTermDebtType-LenderI" id="ixv-6550">2028-03-17</us-gaap:DebtInstrumentMaturityDate>
    <fil:ConvertibleDebtOutstanding
      contextRef="E26Q1_ShortTermDebtType-LenderI"
      decimals="INF"
      id="ixv-6551"
      unitRef="USD">93750</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E26Q1_ShortTermDebtType-LenderI"
      decimals="INF"
      id="ixv-6552"
      unitRef="USD">75334</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E26Q1_ShortTermDebtType-LenderI"
      decimals="INF"
      id="ixv-6553"
      unitRef="USD">334</fil:ConvertibleDebtInterest>
    <fil:ConvertibleDebtOutstanding
      contextRef="E25_ShortTermDebtType-LenderI"
      decimals="128"
      id="ixv-6554"
      unitRef="USD">0</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E25_ShortTermDebtType-LenderI"
      decimals="128"
      id="ixv-6555"
      unitRef="USD">0</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E25_ShortTermDebtType-LenderI"
      decimals="128"
      id="ixv-6556"
      unitRef="USD">0</fil:ConvertibleDebtInterest>
    <fil:ConvertibleDebtOutstanding
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6557"
      unitRef="USD">1656104</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6558"
      unitRef="USD">1358018</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6559"
      unitRef="USD">246154</fil:ConvertibleDebtInterest>
    <fil:ConvertibleDebtOutstanding contextRef="E25" decimals="INF" id="ixv-6560" unitRef="USD">1500003</fil:ConvertibleDebtOutstanding>
    <us-gaap:ConvertibleNotesPayable contextRef="E25" decimals="INF" id="ixv-6561" unitRef="USD">1283269</us-gaap:ConvertibleNotesPayable>
    <fil:ConvertibleDebtInterest contextRef="E25" decimals="INF" id="ixv-6562" unitRef="USD">216734</fil:ConvertibleDebtInterest>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6563"
      unitRef="USD">5573</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6564"
      unitRef="USD">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <fil:UnamortizedDebtDiscount
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6565"
      unitRef="USD">25216</fil:UnamortizedDebtDiscount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="Y26Q1" id="ixv-4588">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;NOTE &lt;/b&gt;&lt;b&gt;7&lt;/b&gt;&lt;b&gt; &#x2013;&#160;STOCKHOLDERS&#x2019; EQUITY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;As of December 31, 2023, the Company was authorized to issue 5,000,000 shares of its preferred stock in one or more series, of which 1,500,000 were designated &#x201c;Series B Preferred Stock&#x201d;. On June 24, 2024, the Board of Directors of the Company approved the designation of one share of preferred stock as &#x201c;Series A Preferred Stock&#x201d;. As of March 31, 2026, the Company was authorized to issue 5,000,000 shares of preferred stock, of which 1,500,000 were designated &#x201c;Series B Preferred Stock&#x201d; and 1 was designated &#x201c;Series A Preferred Stock&#x201d;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;On June 24, 2024, the Board of Directors of the Company approved an increase in the authorized shares of common stock from 100,000,000 to 467,000,000. On March 19, 2025, the Company amended its Articles of Incorporation to increase the number of authorized shares from 467,000,000 to 7,500,000,000 shares.&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;As of March 31, 2026 and December 31, 2025 we were authorized to issue 7,500,000,000 shares of common stock. &lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Common Stock&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;As of March 31, 2026 and December 31, 2025 we were authorized to issue 7,500,000,000 shares of common stock, respectively. Each share of common stock has a $0.001 par value. Each share of common stock entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. The Company had 539,367,487 and 486,895,359 shares of common stock issued and outstanding as of March 31, 2026, and December 31, 2025, respectively.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;For the year ended December 31, 2025, the Company issued 58,234,996 shares of common stock issued to settle $363,166 of accounts payable and accrued expenses.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;For the year ended December 31, 2025, the Company issued 75,000,000 shares of Common stock issued to settle $225,000 accrued expenses - related party.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;For the year ended December 31, 2025, the Company issued 16,666,667 shares of common stock in exchange for consulting services.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;For the year ended December 31, 2025, the Company issued 297,002,793 shares of common stock issued for cash and settlement of accrued interest, net of issuance costs in the amount of $1,012,121.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;During the three months ended March 31, 2026, the Company completed a Regulation A equity issuance pursuant to which it issued 25,572,128 shares of common stock, par value $0.001 per share, at a purchase price of $0.003 per share for aggregate proceeds of approximately $76.7 thousand. A portion of the proceeds was disbursed at closing to repay certain obligations and pay offering-related legal costs. &lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;During the three months ended March 31, 2026, the Company issued 26,900,000 shares of common stock in connection with the conversion of $21.5 thousand of accrued interest under an outstanding convertible promissory note. The conversion was effected in accordance with the terms of the note and resulted in a reclassification of the accrued interest liability to equity, with no gain or loss recognized upon conversion.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Series A Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;As of March 31, 2026 and December 31, 2025 we were authorized to issue 1 shares of Series A Preferred Stock, $0.001 par value. The holder of the Series A Preferred is entitled to cast that number of votes on all matters presented for stockholder vote to the stockholders of the Corporation that when taking into account the votes entitled to be cast by the Series A Preferred stockholder is equal to seventy-five percent (75%) of the total shares authorized to vote on such matter(s) and such holder shall vote along with holders of the Corporation&#x2019;s Common Stock on such matters. Additionally, the Series A Preferred Stock is convertible into 9,793,754 shares of Company common stock at the option of the holder. &lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;&lt;i&gt;Series B Preferred Stock - &lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;Mezza&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;nine&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt; Equity&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The Series B Preferred Stock is recorded as mezzanine equity in accordance with ASC 480, &#x201c;&lt;i&gt;Distinguishing Liabilities from Equity&lt;/i&gt;&#x201d;. The Series B Shares are recorded as mezzanine equity in accordance with ASC 480 because the Company may be obligated to issue a variable number of shares at a fixed price known at inception and there is no maximum number of shares that could potentially be issued upon conversion. In this instance, cash settlement would be presumed and the Series B Shares are classified as mezzanine equity in accordance with ASC 480-10-S99. Immediately upon effectiveness of the registration statement registering for resale of all the common stock issuable under the Series B Shares, all outstanding Series B Shares shall automatically convert into common stock. As of March 31, 2026 and December 31, 2025 the Company was authorized to issue 1,500,000 shares of Series B Preferred Stock.&lt;/span&gt;&lt;/p&gt;
</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="E25"
      decimals="INF"
      id="ixv-6566"
      unitRef="Shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="E25_StClStock-SeriesBPrefStock"
      decimals="INF"
      id="ixv-6567"
      unitRef="Shares">1500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6568"
      unitRef="Shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="E26Q1_StClStock-SeriesBPrefStock"
      decimals="INF"
      id="ixv-6569"
      unitRef="Shares">1500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="I240623"
      decimals="INF"
      id="ixv-6570"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="I240624"
      decimals="INF"
      id="ixv-6571"
      unitRef="Shares">467000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="I240624"
      decimals="INF"
      id="ixv-6572"
      unitRef="Shares">467000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="E25Q1"
      decimals="INF"
      id="ixv-6573"
      unitRef="Shares">7500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6574"
      unitRef="Shares">7500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="E25"
      decimals="INF"
      id="ixv-6575"
      unitRef="Shares">7500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6576"
      unitRef="Shares">7500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="E25"
      decimals="INF"
      id="ixv-6577"
      unitRef="Shares">7500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="E25_StClStock-SeriesAPrefStock"
      decimals="INF"
      id="ixv-6578"
      unitRef="UsdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="E26Q1_StClStock-SeriesAPrefStock"
      decimals="INF"
      id="ixv-6579"
      unitRef="UsdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6580"
      unitRef="Shares">539367487</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6581"
      unitRef="Shares">539367487</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="E25"
      decimals="INF"
      id="ixv-6582"
      unitRef="Shares">486895359</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="E25"
      decimals="INF"
      id="ixv-6583"
      unitRef="Shares">486895359</us-gaap:CommonStockSharesOutstanding>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpensesShare
      contextRef="Y25Q1_StockIssuance-StockIssuance8_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6584"
      unitRef="Shares">58234996</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpensesShare>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses
      contextRef="Y25Q1_StockIssuance-StockIssuance8"
      decimals="INF"
      id="ixv-6585"
      unitRef="USD">363166</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
    <fil:CommonStockIssuedToSettleAccruedExpensesRelatedPartyShares
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6586"
      unitRef="Shares">75000000</fil:CommonStockIssuedToSettleAccruedExpensesRelatedPartyShares>
    <fil:CommonStockIssuedToSettleAccruedExpensesRelatedParty
      contextRef="Y26Q1"
      decimals="INF"
      id="ixv-6587"
      unitRef="USD">225000</fil:CommonStockIssuedToSettleAccruedExpensesRelatedParty>
    <fil:IssuanceOfCommonStockInExchangeForConsultingServicesShares
      contextRef="Y26Q1_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6588"
      unitRef="Shares">16666667</fil:IssuanceOfCommonStockInExchangeForConsultingServicesShares>
    <fil:CommonStockIssuedForCashAndSettlementOfAccruedInterestNetOfIssuanceCostsShares
      contextRef="Y25_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6589"
      unitRef="Shares">297002793</fil:CommonStockIssuedForCashAndSettlementOfAccruedInterestNetOfIssuanceCostsShares>
    <fil:CommonStockIssuedForCashAndSettlementOfAccruedInterestNetOfIssuanceCosts contextRef="Y25" decimals="INF" id="ixv-6590" unitRef="USD">1012121</fil:CommonStockIssuedForCashAndSettlementOfAccruedInterestNetOfIssuanceCosts>
    <fil:SharesIssuedForCashSettlementOfAccountsPayableAndAccruedExpensesAndThirdPartyCostsShares
      contextRef="Y26Q1_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6591"
      unitRef="Shares">25572128</fil:SharesIssuedForCashSettlementOfAccountsPayableAndAccruedExpensesAndThirdPartyCostsShares>
    <fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpensesShare
      contextRef="Y26Q1_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6592"
      unitRef="Shares">26900000</fil:CommonStockIssuedToSettleAccountsPayableAndAccruedExpensesShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="E25_StClStock-SeriesAPrefStock"
      decimals="INF"
      id="ixv-6593"
      unitRef="UsdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="E26Q1_StClStock-SeriesAPrefStock"
      decimals="INF"
      id="ixv-6594"
      unitRef="UsdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <fil:ExchangeOfCommonStockForSeriesAPreferredStockShares
      contextRef="Y26Q1_StEqComps-CommonStock"
      decimals="INF"
      id="ixv-6595"
      unitRef="Shares">-9793754</fil:ExchangeOfCommonStockForSeriesAPreferredStockShares>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="E25_StClStock-SeriesBPrefStock"
      decimals="INF"
      id="ixv-6596"
      unitRef="Shares">1500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="E26Q1_StClStock-SeriesBPrefStock"
      decimals="INF"
      id="ixv-6597"
      unitRef="Shares">1500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock contextRef="Y26Q1" id="ixv-4662">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;NOTE 8 - STOCK BASED COMPENSATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;Effective July 15, 2024, the Company adopted the AIBiotics, Inc. 2024 Equity Incentive Plan (the "2024 Plan"), which limits the number of shares that may be issued pursuant to the 2024 Plan to 50,000,000 shares of common stock. As of March 31, 2026, there have not been any stock-based compensation issuances under the 2024 Plan.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;On January 13, 2026, the Company&#x2019;s Board of Directors approved the adoption of the 2026 Equity Incentive Plan (the &#x201c;Plan&#x201d;), subject to stockholder approval. The Plan provides for the issuance of up to 500,000,000 shares of common stock for equity-based awards, including stock options, restricted stock, restricted stock units, and other equity or cash-based incentives, to employees, directors, consultants, and other service providers. The Plan is intended to align employee and shareholder interests and to support long-term growth and retention.  As of March 31, 2026, there have not been any stock-based compensation issuances under the 2026 Plan.&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Warrants Issued&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;The following table reflects a summary of Common Stock warrants outstanding and warrant activity during the three months ended March 31, 2026, and 2025:&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:9.94%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Underlying&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:20.24%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:27.56%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Weighted Average Term (Years)&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Warrants outstanding at January 1, 2025&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;166,667&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1.50&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;0.06&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Granted&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Exercised&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Forfeited/Expired&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;(166,667)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;1.50&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Warrants outstanding at March 31, 2025&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Warrants outstanding at January 1, 2026&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Granted&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Exercised&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Forfeited/Expired &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Warrants outstanding and exercisable at March 31, 2026&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;$&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;The intrinsic value of warrants outstanding as of March 31, 2026 was $0.&lt;/p&gt;
</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <fil:ConsultingAgreementDescription
      contextRef="Y25Q1_PlanName-MayConsultingAgreement"
      id="ixv-6599">On January 13, 2026, the Company&#x2019;s Board of Directors approved the adoption of the 2026 Equity Incentive Plan (the &#x201c;Plan&#x201d;), subject to stockholder approval. The Plan provides for the issuance of up to 500,000,000 shares of common stock for equity-based awards, including stock options, restricted stock, restricted stock units, and other equity or cash-based incentives, to employees, directors, consultants, and other service providers. The Plan is intended to align employee and shareholder interests and to support long-term growth and retention.  As of March 31, 2026, there have not been any stock-based compensation issuances under the 2026 Plan.</fil:ConsultingAgreementDescription>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="Y26Q1" id="ixv-4678">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:9.94%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Underlying&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:20.24%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:27.56%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&lt;b&gt;Weighted Average Term (Years)&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:center"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Warrants outstanding at January 1, 2025&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;166,667&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1.50&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;0.06&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Granted&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Exercised&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Forfeited/Expired&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;(166,667)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;1.50&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Warrants outstanding at March 31, 2025&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Warrants outstanding at January 1, 2026&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Granted&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Exercised&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Forfeited/Expired &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0;text-align:right"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;Warrants outstanding and exercisable at March 31, 2026&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;$&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt Times New Roman;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt Times New Roman;margin:0"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="E24"
      decimals="INF"
      id="ixv-6600"
      unitRef="Shares">166667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="E24"
      decimals="INF"
      id="ixv-6601"
      unitRef="UsdPerShare">1.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="Y24" id="ixv-6602">P0Y21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="Y25Q1"
      decimals="128"
      id="ixv-6603"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="Y25Q1"
      decimals="128"
      id="ixv-6604"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <fil:CommonStockIssuedOnCashlessExerciseOfWarrantShares
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6605"
      unitRef="Shares">166667</fil:CommonStockIssuedOnCashlessExerciseOfWarrantShares>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="Y25Q1"
      decimals="INF"
      id="ixv-6606"
      unitRef="UsdPerShare">1.5</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="E25Q1"
      decimals="128"
      id="ixv-6607"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="E25Q1"
      decimals="128"
      id="ixv-6608"
      unitRef="UsdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="E25"
      decimals="128"
      id="ixv-6609"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="E25"
      decimals="128"
      id="ixv-6610"
      unitRef="UsdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="Y26Q1"
      decimals="128"
      id="ixv-6611"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="Y26Q1"
      decimals="128"
      id="ixv-6612"
      unitRef="UsdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <fil:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
      contextRef="Y26Q1"
      decimals="128"
      id="ixv-6613"
      unitRef="Pure">0</fil:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm>
    <fil:CommonStockIssuedOnCashlessExerciseOfWarrantShares
      contextRef="Y26Q1"
      decimals="128"
      id="ixv-6614"
      unitRef="Shares">0</fil:CommonStockIssuedOnCashlessExerciseOfWarrantShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="Y26Q1"
      decimals="128"
      id="ixv-6615"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="Y26Q1"
      decimals="128"
      id="ixv-6616"
      unitRef="UsdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="E26Q1"
      decimals="128"
      id="ixv-6617"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="E26Q1"
      decimals="128"
      id="ixv-6618"
      unitRef="UsdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="E26Q1"
      decimals="INF"
      id="ixv-6619"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="Y26Q1" id="ixv-5142">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;NOTE&#160;9 &#x2013;&#160;COMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;On November 17, 2021, the Company entered into an Executive Consulting Agreement (the &#x201c;Agreement&#x201d;) with Benjamin Kaplan whereby Mr. Kaplan was appointed as CEO of the Company (see Note 5 &#x2013;&#160;Related Party Transactions).&lt;/p&gt;
</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="Y26Q1" id="ixv-5149">&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&lt;b&gt;NOTE 1&lt;/b&gt;&lt;b&gt;0&lt;/b&gt;&lt;b&gt; &#x2013;&#160;SUBSEQUENT EVENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;The Company has evaluated subsequent events from March 31, 2026 through the issuance date of these financial statements, and there are no events requiring disclosure except for those described below.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;Between April 7, 2026 and May 15, 2026, the Company issued 125,951,490 shares of common stock as consideration to a lender in exchange for the settlement of $62,976 of accrued interest.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="background-color:#FFFFFF"&gt;On April 29, 2026, the Company issued 16,666,667 shares of common stock to an investor in exchange for cash consideration of $50,000.&lt;/span&gt;&lt;/p&gt;
</us-gaap:SubsequentEventsTextBlock>
</xbrl>
